Status:

UNKNOWN

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

Lead Sponsor:

Ahn-Gook Pharmaceuticals Co.,Ltd

Conditions:

Healthy Male Subjects

Eligibility:

MALE

20-45 years

Phase:

PHASE1

Brief Summary

Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects Secondary object : Evaluate Dose-response of S...

Eligibility Criteria

Inclusion

  • Adult healthy males 20 to 45 years at screening
  • BMI : 19kg/m2 \~ 26 kg/m2
  • Blood Pressure : "140 mmHg ≥ sitting SBP ≥ 90 mmHg, 95 mmHg ≥ sitting DBP ≥ 50 mmHg"

Exclusion

  • Have history of significant hepatic, renal gastrointestinal, pulmonary, musculoskeletal, endocrine, neuropsychiatric, hematologic, cardiovascular diseases
  • Have a gastrointestinal disease(ex : Crohn's disease, gastrointestinal ulcer) or surgery (except for Appendectomy, hernia repair) affected the absorption of medications
  • Have history of GERD, Gastric ulcer, Duodenal ulcer and H.pylori positive
  • Hypersensitivity reactions to drugs of clinically significant hypersensitivity reactions in the history of benzimidazole (ex: pantoprazole, NSAID, antibiotic)
  • Have a history of drug abuse
  • unusual diet affected the absorption, distribution, metabolism, excretion of medications
  • Subject who treated with any investigational drugs within 90 days before the administration of investigational drug
  • Subject who takes inhibitors and inducers of drug metabolizing enzyme (Barbiturates etc.) within 30days
  • Previously donate whole blood within 60 days or component blood within 30 days or transfusion within 30 days
  • Subject who have taken habitually caffeine (caffeine \> 5 units/day)
  • Subject who have drunken habitually (alcohol \> 21 units/week, 1 unit = pure alcohol 10ml)or who are unable to quit drinking during this study or smoker
  • Subjects deemed ineligible by investigator based on other reasons

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT01882296

Last Update

June 20 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.